About Puma Biotechnology Inc
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
Puma Biotechnology Inc (PBYI) Stock Score & Signals
Puma Biotechnology Inc (PBYI) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 30 out of 100.
2BB score and signals
Puma Biotechnology Inc’s current 2BB score is 30 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 34 | Low |
| Momentum | 38 | Weakening |
| Financial strength | 65 | Strong |
| Quality | 94 | Very Strong |
| Risk | 24 | Low |
Company facts
| Headquarters | Los Angeles, California, United States |
| Founded | 2007 |
| Employees | 179 |
| P/E ratio | 19.77 |
| 52-week range | $4.58 – $10.50 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-02-24 | — | 0.2346 | — | $68.54M |
| 2026-10-29 | — | 0.0918 | — | $58.65M |
| 2026-08-06 | — | 0.0408 | — | $54.06M |
| 2026-05-07 | -0.07 | -0.1326 | $44.80M | $42.84M |